| 摘要 |
A composition for accelerating fibulin-5 production and/or enhancing fibulin-5 activity, which contains as an active ingredient one or more drugs selected from the group consisting of Caesalpinia crista extract, Psophocarpus tetragonolobus extract, phytic acid and physiologically acceptable salts thereof, and L-hydroxyproline and physiologically acceptable salts thereof.
|
